APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Functional Dyspepsia Drug

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Types
Prokinetic Drugs · Gastric Antisecretory Drugs · Others
Applications
Hospitals · Drugstores

5 editions30 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Functional Dyspepsia DrugCompare research options for Functional Dyspepsia Drug

Pharma & Healthcare

Biosimilar Insulin

Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (hereafter called biosimilars or follow-on biologics) are designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's patent holder. Producers of biosimilars use…

Types
Biosimilar Insulin Glargine · Biosimilar Insulin Lispro · Other
Applications
Hospital · Retail Pharmacy · Others

5 editions29 December 2025

View 5 research editions
APO Research, Inc.